Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Provider Recommendation, HPV Vaccine Receipt Linked

J Pediatr; ePub 2018 Nov 15; Lu, Yankey, et al

Receiving a provider recommendation for vaccination was significantly associated with receipt of human papillomavirus (HPV) vaccine among male adolescents, indicating that a provider recommendation for vaccination is an important approach to increase vaccination coverage. This according to a recent study that aimed to assess HPV vaccination coverage among adolescents by provider recommendation status. The 2011-2016 National Immunization Survey-Teen data were used to assess HPV vaccination coverage among male adolescents by provider recommendation status. Multivariable logistic analyses were conducted to evaluate associations between HPV vaccination and provider recommendation status. Researchers found:

  • HPV vaccination coverage among male adolescents increased from 8.3% in 2011 to 57.3% in 2016.
  • Likewise, the prevalence of provider recommendation increased from 14.2% in 2011 to 65.5% in 2016.
  • In 2016, HPV coverage was higher in male adolescents with a provider recommendation than in those without a provider recommendation (68.8% vs 35.4%).
  • In multivariable logistic regression, characteristics independently associated with a higher likelihood of HPV vaccination included receipt of a provider recommendation, age 16-17 years, black or Hispanic race/ethnicity, any Medicaid insurance, ≥2 physician contacts in the previous 12 months, and urban or suburban residence.

Citation:

Lu P-J, Yankey D, Fredua B, et al. Association of provider recommendation and human papillomavirus vaccination initiation among male adolescents aged 13-17 years—United States. [Published online ahead of print November 15, 2018]. J Pediatr. doi:10.1016/j.jpeds.2018.10.034.